U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
Lenomorelin (Ghrelin) is a pleiotropic hormone, whose effect on growth hormone secretion, through the growth hormone secretagogue (GHS) receptor, is one of its many actions. It is synthesized principally in the stomach. Ghrelin-producing cells constitute a distinct group of endocrine cells dispersed throughout the gastric mucosa and to a lesser extent in the small intestine and the endocrine pancreas. Ghrelin plasma levels rise during fasting and chronic caloric restriction to stimulate food intake and fat storage and to prevent life-threatening falls in blood glucose. Plasma ghrelin levels decrease after a meal is consumed and in conditions of energy surplus (such as obesity). Ghrelin has emerged as a key player in the regulation of appetite and energy homeostasis. It stimulates food intake and transduces signals to hypothalamic regulatory nuclei that control energy homeostasis. Ghrelin levels are negatively correlated with body mass index (BMI) and insulin resistance. Lenomorelin is a peptide of 28 amino acids, in which the serine 3 residue is n-octanoylated, which is necessary for biological activity.

Approval Year

PubMed

PubMed

TitleDatePubMed
Ghrelin and Growth.
2017
Leptin and Ghrelin in Excessive Gestational Weight Gain-Association between Mothers and Offspring.
2019 May 15
The protective effects of Ghrelin/GHSR on hippocampal neurogenesis in CUMS mice.
2019 Sep 1
Name Type Language
LENOMORELIN ACETATE
Common Name English
GHRELIN HUMAN ACETATE
Preferred Name English
HUMAN GHRELIN ACETATE
Common Name English
GHRELIN (HUMAN) ACETATE
Common Name English
Code System Code Type Description
DRUG BANK
DBSALT002101
Created by admin on Sat Dec 16 00:21:45 GMT 2023 , Edited by admin on Sat Dec 16 00:21:45 GMT 2023
PRIMARY
FDA UNII
4492AYV7VO
Created by admin on Sat Dec 16 00:21:45 GMT 2023 , Edited by admin on Sat Dec 16 00:21:45 GMT 2023
PRIMARY